These results, together with other epidemiological data, suggested that eNOS polymorphisms, other than the Glu298Asp, could play a role in influencing the onset and progression of vascular diseases, including CHD, HF and hypertension (Benjafield and Morris, 2000). This evidence concerns the gene NOS3 and Hypertension.